3D Systems Corporation develops additive manufacturing and digital manufacturing solutions built around 3D printers, materials, software and application engineering services. Its news commonly covers production systems for polymers and metals, NextDent dental printing and materials, SLA technology, factory software such as AddiTrak, and customer deployments in medical, dental, aerospace, defense, transportation, motorsports and industrial markets.
Company updates also include financial results, cost and efficiency programs, leadership changes, regulatory certifications for dental products, and commercial adoption of healthcare and industrial applications. These developments reflect the company’s focus on full-service solutions that combine hardware, materials, software and manufacturing expertise.
3D Systems (NYSE:DDD) has appointed Dr. Toby Cosgrove and Dr. Bon Ku to its Medical Advisory Board, expanding its expertise in regenerative medicine. Dr. Cosgrove, former CEO of the Cleveland Clinic, brings extensive healthcare leadership and innovation experience. Dr. Ku, a leader in healthcare technology, directs the Health Design Lab at Thomas Jefferson University. Their appointments aim to enhance 3D Systems' growth in areas like human tissue printing and medical device innovation. Both professionals are expected to contribute significantly to the company’s strategic direction.
3D Systems Corporation (NYSE: DDD) reported Q2 2022 financial results, with revenue of $140.0 million, a 13.8% decline from Q2 2021. Non-GAAP revenue, excluding divestitures, increased 7.8% due to robust demand in Industrial and Healthcare sectors, despite supply chain issues. The company posted a diluted GAAP loss per share of $0.26. Cash reserves stand at $638.2 million. FY 2022 revenue guidance has been lowered to $530 million - $570 million, citing foreign exchange impacts and decreased customer spending.
3D Systems (NYSE:DDD) announced the appointment of Michael Turner as Executive Vice President and Chief Financial Officer, effective August 29, 2022. Turner, who brings over 20 years of financial expertise, previously served as CFO at Innovative Chemical Products and held various finance leadership roles at Albemarle Corporation. His experience includes driving financial controls and implementing technology-based strategies. CEO Dr. Jeffrey Graves expressed enthusiasm for Turner's impact on the company's growth trajectory. Wayne Pensky is recognized for his interim leadership during the transition.
3D Systems has collaborated with Fleet Space Technologies to develop RF patch antennas for their Alpha satellite constellation. Utilizing the DMP Flex 350 printer, Fleet Space will produce antennas in-house, significantly enhancing production efficiency. The development process, requiring only three weeks for small batch production, leverages advanced additive manufacturing techniques. This partnership aims to improve global connectivity and support sustainable mineral exploration. The DMP Flex 350 allows for precise manufacturing, reducing signal loss and operational costs.
3D Systems (NYSE:DDD) will announce its second quarter 2022 financial results on August 8, 2022, after U.S. market close. The company has scheduled a conference call and webcast for August 9, 2022, at 8:30 a.m. ET to discuss these results. Investors can access the webcast at 3D Systems Investor Relations. This event marks an important opportunity for stakeholders to gain insights into the company's performance and outlook.
3D Systems and EMS-GRILTECH have launched DuraForm® PAx Natural, a pioneering nylon copolymer for Selective Laser Sintering (SLS) platforms. Designed for high-impact and elongation applications, it operates at low temperatures (120°C), enhancing printing efficiency and reducing time to delivery. As the exclusive distributor, 3D Systems reports that this eco-friendly material can increase production throughput and minimize waste, featuring over five years of indoor stability. Early adopters commend its performance, highlighting a shift in the cost structure for SLS technology.
3D Systems has appointed Dr. David J. Shulkin, former U.S. Secretary of Veterans Affairs, to its newly formed Medical Advisory Board. The board's mission is to enhance the company's initiatives in regenerative medicine. Dr. Shulkin, noted for his leadership in healthcare management, aims to guide 3D Systems in expanding its Healthcare Solutions business, primarily focusing on dental and orthopedic applications. His experience in patient-centered care is expected to bolster the company's strategic direction in applying 3D printing technologies in medicine.
United Therapeutics and 3D Systems Corporation have unveiled the world's most complex 3D-printed object – a human lung scaffold – at the LIFE ITSELF Conference in San Diego. The scaffolds, demonstrating gas exchange in animal models, consist of 44 trillion voxels with extensive pulmonary structures and are expected to enter human clinical trials within five years. Additionally, current methods extend the viability of human donor lungs, enhancing transplant availability. This initiative aligns with United Therapeutics’ goal to create an unlimited supply of transplantable organs.
3D Systems (NYSE: DDD) has announced that its management will present at the Stifel 2022 Cross Sector Insight Conference in Boston, MA on June 8 at 3:35 p.m. Eastern Time. A live webcast of the presentation will be accessible on the Events and Presentations section of 3D Systems’ website and will remain available for replay for at least 30 days following the event. This presentation aims to provide insights into the company's advancements in Additive Manufacturing solutions across various industries.
3D Systems (NYSE:DDD) has established its inaugural Medical Advisory Board (MAB), appointing Stephen K. Klasko, MD, MBA, as Chair. The MAB aims to provide strategic guidance for the company's regenerative medicine initiatives as they transition to advanced development and human application. Dr. Klasko, noted for his transformative leadership at Jefferson Health—growing its revenue from $1 billion to over $9 billion—will leverage his expertise to mitigate risks and enhance program objectives. His vision focuses on integrating digital technology with healthcare to improve outcomes and reduce costs.